Joe Trebley
Fondateur chez Scioto Biosciences, Inc.
Profil
Dr. Joe Trebley is a Chief Executive Officer & Director at Scioto Biosciences, Inc. and a Head of Start Up Support & Promotion at IU Ventures.
He is on the Board of Directors at Scioto Biosciences, Inc.
Dr. Trebley was previously employed as a Principal by IN-vivo Ventures LLC, a Director-Technology Development by Kylin Therapeutics, Inc., and a Principal by Purdue Research Foundation.
He received his undergraduate degree from Wabash College, a graduate degree from Wabash College and a doctorate degree from Purdue University.
Postes actifs de Joe Trebley
| Sociétés | Poste | Début |
|---|---|---|
Scioto Biosciences, Inc.
 Scioto Biosciences, Inc. BiotechnologyHealth Technology Scioto Biosciences, Inc. operates as a preclinical stage company. It develops therapies to transform the delivery of microbiome therapeutics. The firm?s platform enhances probiotics that are used for diabetes, neurological disorders, gastrointestinal health and alternatives to in-feed antibiotics. The company was founded by Joseph P. Trebley, Jim Schulz, Goodman Steve, Lauren O. Bakaletz, Michael Bailey and Gail E. Besner in May 2017 and is headquartered in Indianapolis, IN. | Fondateur | 01/05/2017 |
Monon Bioventures LLC
 Monon Bioventures LLC Miscellaneous Commercial ServicesCommercial Services Monon Bioventures LLC provides assistance for turning research into clinical assets. The private company is based in Fishers, IN. The company was founded by Joe Trebley, James Schulz, Kevin Meyer. Joe Trebley has been the CEO since incorporation. | Directeur Général | - |
Anciens postes connus de Joe Trebley
| Sociétés | Poste | Fin |
|---|---|---|
IN-vivo Ventures LLC
 IN-vivo Ventures LLC Investment ManagersFinance IN-vivo Ventures LLC (IN-vivo Ventures ) is a venture capital firm founded in 2003 by Claude Miron. The firm is is headquartered in West Lafayette, Indiana. | Private Equity Investor | - |
Purdue Research Foundation
 Purdue Research Foundation Miscellaneous Commercial ServicesCommercial Services Purdue Research Foundation manages and licenses intellectual property, administers trusts, acquires property, negotiates research contracts and performs other services. The organization was founded in 1930 and is headquartered in West Lafayette, IN. | Corporate Officer/Principal | - |
Kylin Therapeutics, Inc.
 Kylin Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Kylin Therapeutics, Inc., a cutting-edge biotechnology company, employs a revolutionary RNA nanoparticle technology platform called 'pRNA' to exploit the enormous potential of RNA interference (RNAi) for treatment of many common diseases. This visionary platform has enormous potential to meet the huge market opportunity for treating cancer and other diseases with RNA-based therapeutics. The unique capabilities of the platform have enabled Kylin to overcome the most significant challenges in the development of RNA-based therapies. The formation of Kylin Therapeutics Inc., is a result of a joint partnership between IN-vivo Ventures, LLC, and Golden Pine Ventures, LLC. Together, these two companies can leverage their alliance partners and strong Board of Directors to ensure Kylin's success. A lean, cross-functional management team is set to effect early stage success. This team provides the essential ingredients to develop and promote Kylin to the next level. It is the goal of this team to provide early stage validation and market traction to attract world-class operational management with relevant credentials, track records, and operational experience. | Directeur Technique/Scientifique/R&D | - |
Formation de Joe Trebley
| Wabash College | Graduate Degree |
| Purdue University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Kylin Therapeutics, Inc.
Kylin Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Kylin Therapeutics, Inc., a cutting-edge biotechnology company, employs a revolutionary RNA nanoparticle technology platform called 'pRNA' to exploit the enormous potential of RNA interference (RNAi) for treatment of many common diseases. This visionary platform has enormous potential to meet the huge market opportunity for treating cancer and other diseases with RNA-based therapeutics. The unique capabilities of the platform have enabled Kylin to overcome the most significant challenges in the development of RNA-based therapies. The formation of Kylin Therapeutics Inc., is a result of a joint partnership between IN-vivo Ventures, LLC, and Golden Pine Ventures, LLC. Together, these two companies can leverage their alliance partners and strong Board of Directors to ensure Kylin's success. A lean, cross-functional management team is set to effect early stage success. This team provides the essential ingredients to develop and promote Kylin to the next level. It is the goal of this team to provide early stage validation and market traction to attract world-class operational management with relevant credentials, track records, and operational experience. | Commercial Services |
IN-vivo Ventures LLC
IN-vivo Ventures LLC Investment ManagersFinance IN-vivo Ventures LLC (IN-vivo Ventures ) is a venture capital firm founded in 2003 by Claude Miron. The firm is is headquartered in West Lafayette, Indiana. | Finance |
Purdue Research Foundation
Purdue Research Foundation Miscellaneous Commercial ServicesCommercial Services Purdue Research Foundation manages and licenses intellectual property, administers trusts, acquires property, negotiates research contracts and performs other services. The organization was founded in 1930 and is headquartered in West Lafayette, IN. | Commercial Services |
Scioto Biosciences, Inc.
Scioto Biosciences, Inc. BiotechnologyHealth Technology Scioto Biosciences, Inc. operates as a preclinical stage company. It develops therapies to transform the delivery of microbiome therapeutics. The firm?s platform enhances probiotics that are used for diabetes, neurological disorders, gastrointestinal health and alternatives to in-feed antibiotics. The company was founded by Joseph P. Trebley, Jim Schulz, Goodman Steve, Lauren O. Bakaletz, Michael Bailey and Gail E. Besner in May 2017 and is headquartered in Indianapolis, IN. | Health Technology |
Monon Bioventures LLC
Monon Bioventures LLC Miscellaneous Commercial ServicesCommercial Services Monon Bioventures LLC provides assistance for turning research into clinical assets. The private company is based in Fishers, IN. The company was founded by Joe Trebley, James Schulz, Kevin Meyer. Joe Trebley has been the CEO since incorporation. | Commercial Services |
